Qnasl Generic Name & Formulations
Beclomethasone dipropionate 40mcg, 80mcg; per actuation; non-aqueous nasal spray soln.
Aerosol 40mcg—4.9g (60 actuations), 8.7g (120 actuations); 80mcg—8.7g (120 actuations)
Seasonal and perennial allergic rhinitis.
Qnasl Dosage and Administration
Adults and Children
<4yrs: not established. 4–11yrs: 1 spray (40mcg) in each nostril once daily; max: 2 sprays per day. ≥12yrs: 2 sprays (80mcg) in each nostril once daily; max: 4 sprays per day.
Qnasl Boxed Warnings
Avoid in recent nasal septal ulcers, nasal surgery, or nasal trauma until healed. Monitor periodically for possible changes in nasal mucosa or Candida infection with long-term use. Discontinue if nasal erosion/ulceration or Candida infection occur (treat with local therapy). Change in vision, history of increased intraocular pressure, blurred vision, glaucoma, and/or cataracts: monitor closely. Respiratory tract tuberculosis. Untreated infections (eg, fungal, bacterial, viral, ocular herpes simplex). If exposed to measles or chickenpox, consider anti-infective prophylactic therapy. If adrenal insufficiency exists following systemic corticosteroid therapy, replacement with intranasal corticosteroids may exacerbate symptoms of adrenal insufficiency (eg, lassitude, depression). Monitor for hypercorticism and adrenal suppression (if occur discontinue gradually). Monitor for growth suppression in children. Avoid eyes, mouth and face. Pregnancy (Cat.C). Nursing mothers.
Qnasl Adverse Reactions
Nasal discomfort, epistaxis, headache, pyrexia, upper respiratory tract infection, nasopharyngitis; hypersensitivity reactions (discontinue if occurs).
Qnasl Clinical Trials
Qnasl Patient Counseling